Destiny Pharma Plc (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development of the antibacterial products. The company provides XF drug platform to address multi drug resistant microbial pathogens that cause infections. It offers clinical and preclinical assets for the treatment and prevention of bacterial infections. Destinys products find application in the treatment of lung infection, gram positive infection, gram negative infection and post surgical staphylococcal infection, among others. The company has its operations through a network of industry, governments and academia. Destiny is headquartered in Brighton, the UK.

Destiny Pharma Plc (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Destiny Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Destiny Pharma Raises More Than USD4.7 Million in Venture Financing 10
Partnerships 11
Destiny Pharma Enters into Research Agreement with Aston University 11
Destiny Pharma Enters into Agreement with China Medical System 12
Equity Offering 13
Destiny Pharma Raises USD2.4 Million in Private Placement of Shares 13
Destiny Pharma Raises USD19.8 Million in IPO 14
Destiny Pharma Plc - Key Competitors 15
Destiny Pharma Plc - Key Employees 16
Destiny Pharma Plc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Sep 26, 2018: Destiny Pharma: Interim results for the six months ended 30 June 2018 18
Sep 27, 2017: Destiny Pharma: Interim Results for the 6 Months Ended 30 June 2017 22
Corporate Communications 23
Sep 26, 2018: Destiny Pharma announces appointment of Chief Medical Officer 23
Sep 06, 2018: Destiny Pharma: Directorate Change 24
May 30, 2018: Destiny Pharma Establishes the Scientific Advisory Board 25
Apr 13, 2017: Destiny Pharma announces appointment of new CEO 27
Government and Public Interest 28
Jan 29, 2018: $1bn rewards proposed at Davos 2018 for new antibiotics 28
Other Significant Developments 29
Oct 19, 2018: Destiny Pharma: BIA celebrates UK bioscience in creating innovative new drugs and treatment for patients 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List Of Tables


Destiny Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Destiny Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Destiny Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Destiny Pharma Raises More Than USD4.7 Million in Venture Financing 10
Destiny Pharma Enters into Research Agreement with Aston University 11
Destiny Pharma Enters into Agreement with China Medical System 12
Destiny Pharma Raises USD2.4 Million in Private Placement of Shares 13
Destiny Pharma Raises USD19.8 Million in IPO 14
Destiny Pharma Plc, Key Competitors 15
Destiny Pharma Plc, Key Employees 16

List Of Figures


Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Destiny Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Destiny Pharma Plc (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development

USD 250 View Report

Destiny Pharma Ltd (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Destiny Pharma Ltd (Destiny) is a drug discovery company that offers clinical development and commercial exploitation of the antibacterial products. The company provides XF drug platform to address multi drug

USD 250 View Report

Midatech Pharma Plc (MTPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The companys products include gelclair, oravig, soltamox and zuplenz. It conducts

USD 250 View Report

Immupharma Plc (IMM) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain,

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available